Design of a Phase 1/2 Study of an AAV9‐based Gene Therapy for Fronto‐temporal Dementia Patients with Pathogenic GRN Mutations (PROCLAIM Trial)
Alzheimer's & Dementia（2020）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined